Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

PTC Therapeutics to file new Phase III data for genetic muscle disorder drug in Canada

March 15, 2016 Manufacturing and Production, Research and Development Canada, PTC Therapeutics, Translarna, nonsense mutation Duchenne muscular dystrophy, phase III

PTC Therapeutics (Nasdaq: PTCT) said it does not expect the Canadian regulators to review its trial drug to treat a …
News
adocia_lilly

Adocia and Lilly report positive early results for ultra-rapid insulin

March 15, 2016 Manufacturing and Production, Research and Development Adocia, BioChaperone Lispro, Eli Lilly, insulinm

Eli Lilly and development partner Adocia have announced today positive topline results from a Phase 1b clinical trial of ultra-rapid …
News

UPDATE: Pfizer gets interim stay on cough syrup ban

March 15, 2016 Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India

Shares in Pfizer India continued to tumble for a second day even as an Indian court granted the company a …
News

Genentech cancer immunotherapy gets Priority FDA Review in bladder cancer

March 15, 2016 Manufacturing and Production, Research and Development FDA, Genentech, Roche, atezolizumab, bladder cancer, priority review

The US FDA has granted Roche subsidiary Genentech a Priority Review for atezolizumab in treating advanced bladder cancer, whose disease …
News
gwpharma

GW Pharma shares more than double after positive Phase III trials for epilepsy drug

March 15, 2016 Manufacturing and Production, Research and Development Epidiolex, GW Pharma, US FDA, epilepsy in children, phase III

Shares in UK-based GW Pharmaceuticals (Nasdaq: GWPH) more than doubled on the Nasdaq Monday after the company announced positive results …
News
janssen_latest_logo_on_sign_closer

Janssen’s Zytiga boosts survival in early-stage prostate cancer

March 14, 2016 Research and Development, Sales and Marketing Janssen, Zytiga, abiraterone, prednisone, prostate cancer

Janssen has announced data from a post-hoc analysis of a Phase III trial showing that Zytiga plus prednisone boosted overall …
News
xalkori

FDA approves Pfizer sNDA for Xalkori

March 14, 2016 Research and Development, Sales and Marketing Cancer, EMA, NSCLC, Pfizer, Xalkori (crizotinib)

The US FDA has approved Pfizer’s supplemental new drug application (sNDA) for its kinase inhibitor Xalkori in treating patients with …
News
gilead-sciences

EMA starts review of Gilead Sciences’ Zydelig following safety concerns

March 14, 2016 Research and Development, Sales and Marketing EMA, Gilead Sciences, blood cancer, clinical trials, zydelig

Regulators in Europe have initiated a safety review of Gilead Sciences’ (Nasdaq: GILD) blood cancer drug Zydelig (idelalisib) following reports …
News
five_prime_therapeutics_scientist

GSK terminates Five Prime Therapeutics mesothelioma collaboration

March 14, 2016 Research and Development, Sales and Marketing Five Prime Therapeutics, GSK, mesothelioma

GSK is to back out of a licensing deal with California-based Five Prime Therapeutics to develop a mesothelioma drug. Announcing …
News

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016 Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
News
arzerra_novartis

Novartis seeks expanded Arzerra use in US

March 11, 2016 Research and Development Arzerra, CLL, FDA, Genmab, Novartis

Novartis has submitted a supplemental Biologics License Application (sBLA) to the US FDA for the use of Arzerra (ofatumumab) in …
News
shutterstock_38078521

US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump

March 11, 2016 Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA

Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
News
ivf_worldwide_teva_logos

Teva funds research to protect fertility in women diagnosed with cancer

March 11, 2016 Business Services, Research and Development Cancer, IVF Worldwide, Teva, fertility, radiotherapy

Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …
News
vials_purple_liquid

Alphabet’s life science unit makes device to aid gathering of health data for research

March 11, 2016 Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences

Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …
News
sanofi_logo_on_building

Sanofi says its RA drug bested Humira in Phase III study

March 11, 2016 Medical Communications, Research and Development Humira, Regeneron, Sanofi

Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026